Fibroblast Growth Factor 23 in Hemodialysis Patients: Effects of Phosphate Binder, Calcitriol and Calcium Concentration in the Dialysate

Publisher： Karger

E-ISSN： 1660-2110|117|1|c74-c82

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.117, Iss.1, 2010-08, pp. : c74-c82

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of a Non-Calcium-Based Phosphate Binder on Fibroblast Growth Factor 23 in Chronic Kidney Disease

By  

Nephron Clin Pract, Vol. 123, Iss. 1-2, 2013-06 ,pp. : 61-66

Karger

Access to resources Recommend Favorite

Intravenous Calcitriol Therapy Increases Serum Concentrations of Fibroblast Growth Factor-23 in Dialysis Patients with Secondary Hyperparathyroidism

By  

Nephron Clin Pract, Vol. 101, Iss. 2, 2005-06 ,pp. : c94-c99

Karger

Access to resources Recommend Favorite

Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients

By Inaba M.   Okuno S.   Imanishi Y.   Yamada S.   Shioi A.   Yamakawa T.   Ishimura E.   Nishizawa Y.  

Osteoporosis International, Vol. 17, Iss. 10, 2006-10 ,pp. : 1506-1513

Springer Publishing Company

Access to resources Recommend Favorite

Phosphaturic Effect of FGF23 in PD

By  

THERAPEUTIC APHERESIS AND DIALYSIS, Vol. 19, Iss. 1, 2015-02 ,pp. : 73-80

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of Reduced Dialysate Calcium on Calcium-Phosphorus Product and Bone Metabolism in Hemodialysis Patients

By  

Nephron Clin Pract, Vol. 96, Iss. 1, 2004-11 ,pp. : c3-c9

Karger

Access to resources Recommend Favorite